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Mechanistic insights into isoform-dependent
and species-specific regulation of bile salt export
pump by farnesoid X receptor
Xiulong Song, Yuan Chen, Leila Valanejad, Rajani Kaimal, Bingfang Yan, Matthew Stoner,
and Ruitang Deng1
Department of Biomedical and Pharmaceutical Sciences, Center for Pharmacogenomics and Molecular
Therapy, University of Rhode Island, Kingston, RI 02881

Bile acid homeostasis is achieved through an enterohepatic circulation. Canalicular secretion of bile acids through
bile salt export pump (BSEP, ABCB11) is the rate-limiting
step in the circulation (1, 2). Modulation of BSEP expression or function by inherited or acquired factors has profound impact on biliary and intrahepatic bile acid levels.
Indeed, impairment of BSEP function or expression has
been directly linked to such diseases as progressive familial intrahepatic cholestasis type 2 (3–6), benign recurrent
intrahepatic cholestasis (7–9), intrahepatic cholestasis of
pregnancy (10, 11), drug-induced cholestasis (12), and liver
cancer (6, 13, 14).
BSEP expression is coordinately regulated by distinct
but related transactivation pathways (15–19), notably the
bile acids/farnesoid X receptor (FXR, NR1H4) signaling
pathway (15, 16). Activation of FXR by bile acids strongly
induces BSEP expression in vitro and in vivo (15, 16). Such
feed-forward regulation of BSEP by bile acid/FXR is considered a major mechanism for preventing excessive accumulation of toxic bile acids in hepatocytes. Two FXR
genes, FXR␣ and FXR␤, have been identified (20–22).
FXR␣ is functional in all the species tested, while FXR␤ is
a pseudogene in humans (22). Four isoforms of FXR␣
(FXR␣1–4) have been identified as a result of alternative
promoter and splicing (23, 24). Isoforms FXR␣1 and FXR␣2
are predominantly expressed in the liver and adrenal
glands, whereas isoforms FXR␣3 and FXR␣4 are primarily
expressed in the kidneys and intestines in humans (23).
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Abstract Expression of bile salt export pump (BSEP) is
regulated by the bile acid/farnesoid X receptor (FXR) signaling pathway. Two FXR isoforms, FXR␣1 and FXR␣2,
are predominantly expressed in human liver. We previously
showed that human BSEP was isoform-dependently regulated by FXR and diminished with altered expression of
FXR␣1 and FXR␣2 in patients with hepatocellular carcinoma. In this study, we demonstrate that FXR␣1 and
FXR␣2 regulate human BSEP through two distinct FXR responsive elements (FXRE): IR1a and IR1b. As the predominant regulator, FXR␣2 potently transactivated human
BSEP through IR1a, while FXR␣1 weakly transactivated
human BSEP through a newly identified IR1b. Relative expression of FXR␣1 and FXR␣2 affected human BSEP expression in vitro and in vivo. Electrophoretic mobility shift
and chromatin immunoprecipitation assays confirmed the
binding and recruitment of FXR␣1 and FXR␣2 to IR1b
and IR1a. Sequence analysis concluded that IR1b was completely conserved among species, whereas IR1a exhibited
apparent differences across species. Sequence variations
in IR1a were responsible for the observed species difference in BSEP transactivation by FXR␣1 and FXR␣2. In
conclusion, FXR regulates BSEP in an isoform-dependent
and species-specific manner through two distinct FXREs,
and alteration of relative FXR isoform expression may be
a potential mechanism for FXR to precisely regulate human
BSEP in response to various physiological and pathological conditions.—Song, X., Y. Chen, L. Valanejad, R. Kaimal,
B. Yan, M. Stoner, and R. Deng. Mechanistic insights into
isoform-dependent and species-specific regulation of bile
salt export pump by farnesoid X receptor. J. Lipid Res.
2013. 54: 3030–3044.

EXPERIMENTAL PROCEDURES
Reagents and suppliers
Chemicals and reagents for cloning, site-directed mutagenesis,
polymerase-chain reaction (PCR), gel-shift assays, cell cultures,
transfection, and luciferase assays were described previously (28).

Plasmid constructs
Human, mouse, and rat bsep promoter reporters and mutants, including phBSEP (-2.6kb), pmBSEP(-2.6kb), prBSEP(-2kb),
phBSEP(-125b), and phBSEP(-2.6kb)-IR1a-Mut, were prepared
previously (18, 28, 29). Human pTK-3xhIR1a, mouse/rat pTK3xm/rIR1a, and pTK-3xIR1b reporters were constructed by cloning three copies of the corresponding element into pTK-Luc
vector. Element reporters pGL3/p-2xhIR1a and pGL3/p-2xhER2/
IR1a were prepared by cloning two copies of IR1a and ER2/IR1a
element in human BSEP promoter into the pGL3/p vector, respectively. Element reporters, including pElement 1–6, were generated by cloning the corresponding element into the pGL3/p
vector. Expression plasmids for human nuclear receptors FXR␣2
and FXR␣1 were kindly provided by Dr. Matthew Stoner and Dr.
David Mangelsdorf (University of Texas Southwestern Medical
Center), respectively.

IR1b (ATGCCCCTTTACT), and the half ER2 site (AACCCT),
respectively (mutated nucleotides are underlined). Rat bsep promoter mutants prBSEP(-2kb)-IR1a-Mut, prBSEP(-2kb)-IR1b-Mut,
prBSEP(-2kb)-IR1ab-Mut, and prBSEP(-2kb)-ER2-Mut were prepared by mutating the IR1a, IR1b, IR1a and IR1b, and the half
ER2 site using prBSEP(-2kb) as templates. Three, four, and three
nucleotides were mutated in IR1a (GGGACATTGATCT), IR1b
(ATGCCCCTTTACT), and the half ER2 site (AAAACT), respectively. Replacement of human IR1a (hIR1a) with mouse/rat IR1a
(m/rIR1a) was achieved through mutagenesis using phBSEP(-2.6kb)
as the template, resulting in a chimeric reporter phBSEP(-2.6kb)-m/
rIR1a. Chimeric reporter prBSEP(-2kb)-hIR1a was made through
mutagenesis by replacing the mouse/rat IR1a (m/rIR1a) with the
human IR1a (hIR1a) using prBSEP(-2kb) as the template. All the
mutants were subjected to sequence confirmation.

Immunohistofluorescence
Normal human liver tissue sections embedded in paraffin
(ab4348) were obtained from Abcam (Cambridge, MA). Deparaffinization, antigen retrieval, and immune staining of the sections
were carried out basically according to the protocol recommended
by the manufactures. Nonspecific binding was blocked by using
5% BSA in 1× TBS containing 0.1% TX-100 for 2 h on shaker at
room temperature. Three types of primary antibodies (Abs) were
applied to individual slides, including rabbit anti-FXR␣1-specific
Abs (custom-made by the NeoBioLab, Woburn, MA), rabbit antiFXR Abs (sc-13063), and rabbit IgG (sc-2027, Santa Cruz Biotechnology) as negative controls. AlexaFluor 594 goat anti-rabbit Abs
(A11012, Invitrogen) was used as the secondary Abs. The sections
were then mounted under a glass cover slip using Vectashield
mounting medium containing 1.5 g/ml DAPI (H-1500, Vector
Laboratories, Burlingame, CA) as nuclei counterstaining. Images
were captured under a confocal microscope at a magnification
of 40× (Zeiss AxioImager M2 Imaging System) with fluorescent
and differential interference contrast (DIC) settings.

Reporter luciferase assay
The reporter luciferase activity assays were carried out using the
human hepatoma Huh 7 cells and rat hepatocellular carcinoma

Liver samples
Snap-frozen healthy human liver samples were obtained
through the Mid-Atlantic Division of the Cooperative Human
Tissue Network (CHTN) (University of Virginia). The protocol
for using human tissues was approved by the Institutional Review
Board (IRB) at the University of Rhode Island.

Site-directed mutagenesis
Mutations were introduced into the templates using a QuickChange site-directed mutagenesis kit according to the manufacturer’s manual (Stratagene) (29). Human BSEP promoter mutants
phBSEP(-2.6kb)-IR1b-Mut, phBSEP(-2.6kb)-IR1ab-Mut, and
phBSEP(-2.6kb)-ER2-Mut were prepared by mutating the IR1b,
IR1a and IR1b, and half ER2 (everted repeat separated by two
nucleotides) sites using phBSEP(-2.6kb) as a template. Six, four,
and two nucleotides were mutated in IR1a (GACGCGTGAATTC),

Fig. 1. Transactivation of BSEP by FXR␣1 and FXR␣2. Human,
mouse, and rat bsep promoter reporters phBSEP(-2.6kb), pmBSEP
(-2.6kb), and prBSEP(-2kb) were cotransfected into human hepatoma Huh 7 cells with either FXR␣1 or FXR␣2 expression plasmid,
followed by treatment of the transfected cells with vehicle DMSO
(0.1%) or CDCA (10 M) for 30 h. Reporter transactivation levels
as luciferase activities were detected with a dual-luciferase reporter
assay system. The firefly luminescence was normalized based on
the Renilla luminescence signal. The data are presented as mean ±
SD of at least three separate experiments. *P < 0.05 between DMSO
and CDCA-treated cells (Student t-test).
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We have recently showed that human BSEP expression
was severely diminished in patients with hepatocellular
carcinoma (HCC) and that such decreased expression of
BSEP correlated with altered relative expression of FXR␣1
and FXR␣2 (25). Similar to human BSEP, FXR␣2 showed
more potent activity than FXR␣1 in transactivating other
hepatic FXR targets, including human syndecan-1 and fibrinogens (26, 27), whereas mouse bsep and small heterodimeric partner (SHP) were regulated by FXR␣1 and
FXR␣2 to similar degrees (24). Currently, the underlying
mechanisms for such isoform-dependent and species-specific regulation of BSEP by FXR are not understood.
In this study, we demonstrate that FXR␣1 and FXR␣2
transactivated human BSEP through two distinct FXR responsive elements (FXRE) that are inverted repeats spaced
by one nucleotide (IR1): IR1b and IR1a, respectively. In addition to total FXR expression levels, relative expression of
FXR␣1 and FXR␣2 affected human BSEP expression in vitro
and in vivo. Further study revealed that sequence variations
in IR1a were responsible for the observed species difference
in transactivation of BSEP by FXR␣1 and FXR␣2.

(HCC) L0 cells (kindly provided by Dr. Jonathan Reicher, Brown
University) in a 24-well plate as described previously (28).

Electrophoretic mobility shift assays
Nuclear extracts of Huh 7 cells transfected with FXR␣1 or
FXR␣2 were prepared using the NE-PER Nuclear and Cytoplasmic Extraction kit (Pierce). The electrophoretic mobility shift
assays (EMSA) were performed using the LightShift Chemiluminescent EMSA kit (Pierce) as described (17). Supershift assays
were carried out using polyclonal Abs against human FXR (sc13063, Santa Cruz Biotechnologies).

Chromatin immunoprecipitation assays
Huh 7 cells seeded in 6-well plates were cotransfected with
400 ng of either FXR␣1 or FXR␣2 and either 400 ng phBSEP

(-2.6kb), phBSEP(-2.6kb)-IR1a-Mut, phBSEP(-2.6kb)-IR1b-Mut,
or phBSEP(-2.6kb)-IR1ab-Mut. Sixteen hours posttransfection,
cells were treated with 10 M CDCA for 24 h. Chromatin preparation and immunoprecipitation (ChIP) assays were performed
essentially as described previously (28). A test set of primers,
BSEP(-260b) and pGL4-R(122), flanking IR1a and IR1b were
used to amplify a 462 bp fragment encompassing sequence from
nucleotides ⫺260 to +80 in the BSEP promoter and 122 nucleotides in the luciferase gene. A negative control set of primers
was included in the assays (28).

Living imaging with in vivo imaging system
Sixteen female CD-1 mice between ages 5 and 8 weeks were
obtained from Charles River Laboratory (Wilmington, MA) and
randomly divided into four groups. Each group of mice was
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Fig. 2. The effects of relative expression levels of FXR␣1 and FXR␣2 on BSEP expression in human liver tissues and Huh 7 cells. (A)
mRNA expression levels of BSEP and total FXR in healthy human liver tissues were determined by TaqMan real-time PCR and plotted
against FXR␣1/FXR␣2 ratios using SigmaPlot version 11.0. The cycle time (Ct) values Ct24.92 for FXR and Ct27.12 for BSEP of one tissue
sample were designated as a relative unit 1. (B) A series of mixtures of FXR␣1 and FXR␣2 plasmid DNA in various FXR␣1/FXR␣2 ratios
(from 1.0, 1.2, 1.4, 1.6 to 1.8) with a constant amount of total FXR at 10, 25, or 50 ng were cotransfected with human BSEP promoter reporter in Huh 7 cells, followed by treatment of the transfected cells with CDCA for 30 h and subsequent detection of luciferase activity.
FXR␣1/FXR␣2 ratios were plotted against total FXR and BSEP promoter transactivation as luciferase activities using SigmaPlot version
11.0. The left figure shows the level and position of each individual sample in the 3D diagram. The right figure is the smooth 3D model
based on the data shown on the left.
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hydrodynamically injected with phBSEP(-2.6kb), prBSEP(-2kb),
phBSEP(-2.6kb)-m/rIR1a, or prBSEP(-2kb)-hIR1a promoter reporter as described previously (25). Luciferase activities were detected by living imaging with in vivo imaging system (IVIS) 48 h
postinjection and captured by a CCD camera with an exposure
time of 45 s (25). The animal protocols were approved by the
Institutional Animal Care and Use Committee (IACUC) at the
University of Rhode Island (URI) and followed the guidelines
outlined in the National Institutes of Health Guide for the Care
and Use of Laboratory Animals.

Quantitative real-time PCR
Total RNA extraction from 14 healthy human and 8 CD-1 mice
liver tissues and subsequent cDNA synthesis and TaqMan realtime PCR detection for total FXR and BSEP were carried out as
reported (17, 25).

Semiquantification of FXR␣1 and FXR␣2
By using human liver cDNA samples as templates, the relative
FXR␣1 and FXR␣2 mRNA levels were determined by the semiquantification methods described previously (25).

Student t-test was applied to pair-wise comparison to determine the statistical significance. Nonparametric Mann-Whitney
test was used for pair-wise comparison for nonnormally distributed data. Values of 0.05 or less were considered significant.

RESULTS
Isoform-dependent and species-specific regulation of
BSEP transactivation by FXR
Four FXR␣ isoforms (FXR␣1–4) have been identified,
with predominant expression of FXR␣1 and FXR␣2 in the
liver (23, 24). Our previous study showed that human
BSEP was regulated by FXR in an isoform-dependent
manner and that alteration of isoform expression was

Relative FXR isoform and total FXR expression affected
the expression levels of human BSEP
In our previous studies, it was shown that the relative
expression levels of FXR␣1 and FXR␣2 correlated with
BSEP expression (25). In this study, the comprehensive
relationships among FXR isoforms, total FXR expression,
and BSEP expression were further investigated. As shown
in Fig. 2A, the expression levels of BSEP and total FXR in
healthy human liver samples were plotted against FXR␣1/
FXR␣2 ratios using SigmaPlot 3D program. Over 27- and
6-fold differences in BSEP and total FXR expression, respectively, were detected among the liver samples. Consistent with FXR’s transactivating role in BSEP regulation,
BSEP expression increased along with increase in total
FXR. However, the relationship between FXR␣1/FXR␣2
ratios and BSEP expression did not exhibit a single trend
(Fig. 2A). At higher levels of total FXR, as expected, BSEP
expression decreased as the FXR␣1/FXR␣2 ratios increased. However, at lower levels of total FXR, BSEP expression increased as the FXR␣1/FXR␣2 ratios increased.
The data thus indicated that BSEP expression in human

Fig. 3. Expression and localization of FXR␣1 and total FXR in human liver tissues. Liver sections were
subjected to immunohistofluorescent assays. FXR␣1- and FXR-specific Abs and rabbit IgG as negative controls were used as primary Abs. Goat anti-rabbit Abs labeled with AlexaFluor 594 was used as the secondary
Abs. Mounting medium containing DAPI (1.5 g/ml) was used as nuclei counterstaining. Images were captured under a confocal microscope at a magnification of 40× with both fluorescent and DIC settings.
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Statistical analysis

associated with dysregulation of BSEP in patients with
HCC (25). In this study, we extended such finding by testing FXR isoform-mediated transactivation of BSEP from
three species, including human, mouse, and rat. Consistent with our previous findings, FXR␣2 exhibited much
more potent activity in transactivating human BSEP than
FXR␣1 in the presence or absence of endogenous FXR
agonist chenodeoxycholic acid (CDCA) (Fig. 1). In contrast,
both mouse and rat bsep were transactivated by FXR␣1
and FXR␣2 in comparable levels (Fig. 1). The results demonstrated that human BSEP was differentially regulated by
FXR␣1 and FXR␣2 with FXR␣2 being the predominant
regulator, whereas mouse and rat bsep were similarly transactivated by the two isoforms.

livers was dictated by the FXR␣1/FXR␣2 ratios as well as
by total FXR expression levels.
To directly evaluate the effect of FXR␣1/FXR␣2 ratios
at various total FXR levels on BSEP transactivation in vitro,
a series of mixtures of FXR␣1 and FXR␣2 plasmid DNA in
various ratios (from 1:1 to 1.8:1) at various amounts of total
FXR (10, 25, or 50 ng) were cotransfected with the human
BSEP promoter reporter in Huh 7 cells, followed by treatment with CDCA. As shown in Fig. 2B, a relationship pattern
comparable to human liver samples (Fig. 2A) was observed
in transfected Huh 7 cells. BSEP transactivation gradually
decreased as the FXR␣1/FXR␣2 ratios increased at a high
level of total FXR plasmid DNA (50 ng) but increased at a
low level of total FXR plasmid DNA (10 ng). The minor differences between the two data sets (Fig. 2) may reflect the
fact that the sample size of human liver samples was relatively small. Taken together, the results demonstrated that
the ratio of FXR␣1/FXR␣2 played an important role in
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Expression and localization of FXR␣1 and total FXR
protein in human liver tissue
Immunohistofluorescence was carried out to investigate
the expression and localization of total FXR and FXR␣1. In
our attempt to generate FXR isoform-specific Abs, antiserum raised against FXR␣1-specific peptide detected FXR␣1
protein specifically, whereas antiserum raised against FXR␣2specific peptide recognized both FXR␣2 and FXR␣1 protein (data not shown) because there are only four extract
amino acids inserted in FXR␣1 compared with FXR␣2.
Therefore, FXR␣1-specific Abs and Abs recognizing both
FXR␣1 and FXR ␣ 2 were used in the immunohistofluor escent assays. As shown in Fig. 3, minimal red fluorescent
signals were detected with rabbit IgG as negative controls
while FXR␣1 and total FXR proteins were readily detected
with FXR␣1- and FXR-specific Abs. Both FXR␣1 and total
FXR proteins were predominantly present in the cytoplasm. As expected, relatively weaker signals were detected
with FXR␣1-specific Abs than with FXR-specific Abs.
Isoform-dependent transactivation of human BSEP
by FXR was not due to a difference in
ligand-mediated activation
In the previous experiments, the potent endogenous
FXR agonist CDCA was used in evaluating human BSEP
transactivation by FXR isoforms. To determine whether
FXR␣1- and FXR␣2 -mediated differential transactivation
of human BSEP is related to specific FXR ligands, a series
of FXR endogenous and exogenous ligands were tested
for their ability to induce FXR␣1- and FXR␣2-mediated
transactivation of human BSEP. The ligands tested include
six endogenous bile acids, including cholic acid (CA),
CDCA, deoxycholic acid (DCA), lithocholic acid (LCA),
ursodeoxycholic acid (UDCA) and glycodeoxycholic acid
(GDCA), a natural product guggulsterone, and two synthetic FXR agonists GW4064 and T0901317. As shown in
Fig. 4A, all the FXR ligands exhibited similar FXR isoformdependent transactivation of human BSEP regardless their
agonistic potency. FXR␣2 consistently transactivated human BSEP at a much higher level than FXR␣1 with each of
the ligands.
In contrast to human BSEP, both mouse and rat bsep
promoters exhibited comparable transactivation activities
by FXR␣1 and FXR␣2, with slightly higher levels with
FXR␣2 in the presence of CDCA in Huh 7 cells (Fig. 1).
Considering the possibility that rat or mouse bsep may
exhibit a different transactivation pattern by FXR␣1 and
FXR␣2 in rat or mouse cells, rat bsep promoter reporter
prBSEP(-2kb) was cotransfected with FXR␣1 or FXR␣2 in
rat HCC L0 cells, followed by treatment with various FXR
ligands. As shown in Fig. 4B, consistent with the data from
Huh 7 cells, FXR␣1 and FXR␣2 exhibited similar transactivation levels with most FXR ligands, except for CDCA
and LCA. FXR␣2 transactivated rat bsep more potently
than did FXR␣1 with CDCA and LCA. However, it should
be emphasized that the differences between FXR␣2 and
FXR␣1 in transactivating human BSEP in Huh 7 cells were

Downloaded from www.jlr.org at Univ of Rhode Island, on January 23, 2019

Fig. 4. Transactivation of BSEP promoters by FXR␣1 and FXR␣2
with various FXR ligands. (A) Human BSEP promoter reporter
phBSEP(-2.6kb) and (B) rat bsep promoter reporter prBSEP(-2kb)
were cotransfected into human hepatoma Huh 7 cells and rat HCC
L0 cells, respectively, with FXR␣1 or FXR␣2, followed by treatment
of transfected cells with various endogenous and exogenous FXR
ligands, including CA (10 M), CDCA (10 M), DCA (10 M),
LCA (10 M), UDCA (10 M), GDCA (10 M), GW4064 (1 M),
GUG (10 M), and T0901317 (1 M). Thirty hours post treatment,
reporter transactivation levels as luciferase activities were detected
with a dual-luciferase reporter assay system. The firefly luminescence was normalized based on the Renilla luminescence signal.
The data are presented as mean ± SD of at least three separate experiments. *P < 0.05 between FXR␣1 and FXR␣2-transfected cells
(Student t-test).

determining human BSEP transactivation and that its effects were influenced by the total FXR expression levels.

much more striking than those with rat bsep in rat HCC
L0 cells. FXR␣2 was 27.1- or 18.9-fold more potent than
FXR␣1 in transacting human BSEP in Huh 7 cells in the
presence of CDCA or LCA, whereas only 2.6- or 4.1-fold
differences were observed between FXR␣2 and FXR␣1 in
transactivating rat bsep in L0 cells with CDCA or LCA.
Taken together, the data indicated that the isoformdependent transactivation of human BSEP by FXR was not
due to a difference between FXR␣1 and FXR␣2 in ligand
binding or ligand-mediated activation. On the other hand,
FXR␣1 and FXR␣2 transactivated rat bsep comparably
with most of the FXR ligands.
Isoform-dependent and species-specific transactivation
of BSEP by FXR was due to a difference in FXRE in
BSEP promoters
Early studies identified an FXRE (named IR1a) in the
BSEP promoter (15, 16). To determine whether the isoformdependent and species-specific transactivation of BSEP is
due to a differential activation of the IR1a by FXR␣1 and
FXR␣2, human and mouse/rat IR1a (hIR1a and m/rIR1a)
reporters were constructed and tested for their ability to
support FXR␣1 or FXR␣2 transactivation. It should be
mentioned that the IR1a sequences are completely conserved in mouse and rat bsep promoters. As shown in
Fig. 5A, FXR␣2 significantly transactivated hIR1a reporter,
whereas no transactivation was detected in cells transfected
with FXR␣1. Conversely, both FXR␣1 and FXR␣2 strongly
transactivated m/rIR1a reporter (Fig. 5B). The results thus
demonstrated that hIR1a only supported FXR␣2 transactivation, while m/rIR1a was capable of mediating both FXR␣1
and FXR␣2 transactivation.

Previous studies revealed that half nuclear receptor
binding site and ER2 (everted repeat separated by two
nucleotides) are commonly found adjacent to the IR1
(30). A half ER2 motif was identified immediately upstream the IR1a (Fig. 5C). Inclusion of the motif in hER2/
IR1a reporter significantly enhanced FXR␣2-mediated transactivation (Fig. 5C), indicating that the half ER2 motif
is required for maximal transactivation of human BSEP
by FXR␣2. However, FXR␣1 still failed to transactivate the
hER2/IR1a reporter, suggesting that FXR␣1 must regulate human BSEP through an additional FXRE.
FXR␣1 transactivated human BSEP through IR1b, a
newly identified FXRE
To determine whether the potential additional FXRE
is present in the minimal human BSEP promoter, the
resultant phBSEP(-125b) reporter was cotransfected with
FXR␣1, followed by treatment with DMSO or CDCA. As
shown in Fig. 6A, similar to the full-length promoter reporter phBSEP(-2.6kb), FXR␣1 significantly transactivated
the minimal promoter reporter, indicating that the potential additional FXRE is located in the minimal promoter
region.
Since no FXREs were predicted by bioinformatic analysis in the region, a series of element reporters covering the
entire region were constructed and evaluated for their
ability to respond to FXR␣1 (Fig. 6B, C). Reporters pElement 1 and 4 exhibited significant induction of activity in
response to CDCA in the presence of FXR␣1, whereas no
induction was detected with other reporters. The data thus
mapped a new functional FXRE (named IR1b) in the overlapped region between pElement 1 and 4 at positions from
Isoform and species-specific regulation of BSEP by FXR
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Fig. 5. Isoform-dependent and species-specific transactivation of IR1a reporters by FXR␣1 and FXR␣2.
(A) Human BSEP IR1a reporter pTK-3xhIR1a, (B) mouse/rat bsep IR1a reporter pTK-3xm/rIR1a, and (C)
human BSEP ER2/IR1a reporter pGL3/p-2xhER2/IR1a were cotransfected with FXR␣1 or FXR␣2, followed
by treatment of the cells with DMSO (0.1%) or CDCA (10 M) for 30 h. Reporter luciferase activities were
detected with the dual-luciferase reporter assay system. The data are presented as mean ± SD of at least three
repeated experiments. *P < 0.05 between DMSO and CDCA-treated cells (Student t-test).

⫺97b to ⫺85b (Fig. 6D). The IR1b was physically close to
IR1a (18 bases from each other). To confirm that the
newly identified IR1b is functional in supporting FXR␣1
transactivation, IR1b reporter pTK-3xIR1b was constructed
and tested. As shown in Fig. 6D, FXR␣1 moderately transactivated IR1b reporter in the presence of CDCA, confirming that FXR␣1 regulates human BSEP through IR1b.
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Fig. 6. FXR␣1 transactivated human BSEP through a newly
identified FXRE, IR1b. (A) Full-length and minimal human BSEP
promoter reporters phBSEP(-2.6kb) and phBSEP(-125b) were
cotransfected with FXR␣1 in Huh 7 cells. Sixteen hours posttransfection, cells were treated with DMSO (0.1%) and CDCA (10 M)
for 30 h, followed by detection luciferase activities with dual-luciferase reporter assay system. The data are presented as mean ±
SD of at least three repeated experiments. (B) A diagram showing
the positions of the six elements in the minimal promoter region.
(C) The six elements were cloned into the pGL3/p-Luc vector, resulting in six element reporters, pElement 1 to 6. Activation of the
six element reporters by FXR␣1 in the presence of CDCA (10 M)
was detected by the dual-luciferase reporter assay system. The data
are presented as mean ± SD of at least three repeated experiments.
*P < 0.05 between DMSO and CDCA-treated cells (Student t-test).
(D) The location and sequence of the newly identified IR1b are
shown in the upper panel. Transactivation of hIR1a and IR1b reporters by FXR␣1 are presented in the lower panel. Reporters pTK3xhIR1a and pTK-3xIR1b were cotransfected into Huh 7 cells with
FXR␣1, followed by treating the cells with DMSO (0.1%) or CDCA
(10 M) for 30 h prior to detection of luciferase activities as described in (A). *P < 0.05 between DMSO and CDCA-treated cells
(Student t-test).

Mutational analysis of IR1a and IR1b in supporting
FXR␣1- and FXR␣2-mediated transactivation of human
and rat bsep
To determine the relative contribution of IR1a, IR1b,
and the half ER2 sites to the transactivation of human and
rat bsep by FXR␣1 and FXR␣2, mutational analyses were
performed in those elements. Double mutation in IR1a
and IR1b was also introduced.
For human BSEP, similar to the IR1a and IR1b double
mutant, IR1b mutant completely lost its ability to respond
to FXR␣1 (Fig. 7A), suggesting that FXR␣1 regulates
human BSEP through IR1b. Although mutation in IR1a
decreased FXR␣1-mediated transactivation, significant
induction remained (Fig. 7A). More significantly, the fold
induction by CDCA over DMSO was comparable between
IR1a mutant and wild-type (wt) (13.1 versus 11.3), indicating that IR1a is required for basal activity but not FXR␣1mediated transactivation. Conversely, mutation in IR1a
almost entirely abolished FXR␣2-mediated transactivation
as did the double mutant (Fig. 7B), consistent with regulation of human BSEP by FXR␣2 through IR1a. Similarly,
the IR1b mutant retained the ability to respond to CDCA
in the presence of FXR␣2 with almost identical fold inductions as the wt (7.9 versus 7.4) (Fig. 7B). Mutation in the
half ER2 motif markedly reduced FXR␣2- but not FXR␣1mediated transactivation (Fig. 7A, B). Taken together, the
data demonstrated that FXR␣1 and FXR␣2 transactivated
human BSEP through IR1b and IR1a, respectively, and
that the ER2 motif is required for maximal FXR␣ 2
transactivation.
Similar mutational analyses were performed with rat
bsep promoter to evaluate species differences. As shown in
Fig. 7C, mutation in IR1a or IR1b resulted in a decrease in
FXR␣1-mediated transactivation. However, significant activation by CDCA remained for both mutants. As expected,
the double mutant almost completely lost its ability to respond to CDCA. The results indicated that different from
human BSEP, FXR␣1 regulated rat bsep through both
IR1a and IR1b. Conversely, mutation in IR1a almost totally
abolished FXR␣2-mediated transactivation as did the double mutant, indicating that FXR␣2 regulates rat bsep
through IR1a. Although mutation in IR1b decreased
FXR␣2-mediated transactivation, significant induction by
CDCA was detected with a comparable fold induction to
the wt (7.7 versus 6.5) (Fig. 7D), indicating that similar to
human BSEP, IR1b is required for basal activity but not
for FXR␣2-mediated transactivation. Mutation in the half
ER2 site had no detectable effect on FXR␣1- and FXR␣2mediated transactivation (Fig. 7C, D), suggesting that different from human BSEP, the half ER2 in rat bsep does
not play any roles in mediating FXR␣2 transactivation.
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Fig. 7. Mutational analysis of IR1a and IR1b in BSEP promoters. Four human BSEP promoter mutants
with mutation in IR1a, IR1b, the half ER2 site, or both IR1a and IR1b were made using human BSEP promoter reporter phBSEP(-2.6kb) as parental template, resulting in mutants phBSEP(-2.6kb)-IR1a-Mut,
phBSEP(-2.6kb)-IR1b-Mut, phBSEP(-2.6kb)-IR1ab-Mut, and phBSEP(-2.6kb)-ER2-Mut. Four equivalent mutants were constructed using rat bsep promoter reporter prBSEP(-2kb) as parental template, resulting in
prBSEP(-2kb)-IR1a-Mut, prBSEP(-2kb)-IR1b-Mut, prBSEP(-2kb)-IR1ab-Mut, and prBSEP(-2kb)-ER2-Mut.
The four human BSEP promoter mutants and wt were cotransfected with (A) FXR␣1 or (B) FXR␣2 into
Huh 7 cells. The four rat bsep promoter mutants and wt were cotransfected with (C) FXR␣1 or (D) FXR␣2.
Sixteen hours posttransfection, cells were treated with DMSO (0.1%) or CDCA (10 M) for 30 h, followed
by detection of luciferase activities by the dual-luciferase reporter assay system. The data are presented as
mean ± SD of at least three repeated experiments. *P < 0.05 between DMSO and CDCA-treated cells (Student t-test). The fold inductions by CDCA over DMSO are presented on the top of the bars.
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Binding of FXR␣1 and FXR␣2 to IR1a and IR1b in vitro
To determine whether FXR isoforms differentially bind
to IR1a and IR1b in vitro, a series of EMSA assays were performed. With hIR1a and m/rIR1a probes, two distinct bands
were shifted for both FXR␣1 and FXR␣2, indicating that
two DNA/protein complexes were formed (Fig. 8A, B). To
determine which band represents the specific binding of
FXR␣1 or FXR␣2 to the probe, competition assays were
carried out. The dominant bottom band was completely
competed out by 10× unlabeled wt but not by mutated
hIR1a or m/rIR1a oligonucleotide, indicating that the
bottom band represented the probe-specific complex. To
confirm that FXR␣1 or FXR␣2 is part of the complex,
supershift assays with Abs against FXR were performed.
Preincubation of FXR Abs with nuclear extracts markedly decreased the shifted band, suggesting that the binding of FXR Abs to FXR interferes with its binding to the
hIR1a or m/rIR1a probe, decreasing the formation of
the DNA/FXR complexes. The data thus demonstrated
that both FXR␣1 and FXR␣2 bound to hIR1a or m/rIR1a
abundantly in vitro. The abundant binding of FXR␣1 to
hIR1a was not expected since FXR␣1 failed to transactivate hIR1a reporter.
3038
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With IR1b as a probe, two similar bands were shifted
with FXR␣1 and FXR␣2. Competition EMSA assays concluded that the bottom band was the specific one. Incubation of FXR Abs with the complex resulted in a supershifted
band (Fig. 8C), indicating that FXR is part of the complex.
It should be emphasized that although similarly shifted
patterns were observed for both FXR␣1 and FXR␣2, the
bands shifted or supershifted with FXR␣1 were much
more abundant than those with FXR␣2, suggesting that
FXR␣1 has a higher binding affinity to IR1b than does
FXR␣2.
FXR␣1 and FXR␣2 were specifically recruited to
IR1b and IR1a, respectively, in human BSEP promoter
in intact cells
Since IR1a and IR1b are located so close to each other,
it was challenging to distinguish FXR recruitment to each
individual site on the endogenous BSEP promoter. We
used human BSEP promoter reporter wt and mutants to
perform ChIP assays. Chromatins were prepared from
Huh 7 cells cotransfected with FXR␣1 or FXR␣2 with human BSEP promoter wt, IR1a, IR1b, or IR1ab mutant. With
FXR␣1, a PCR band was readily detected in cells transfected
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Fig. 8. Binding of FXR␣1 and FXR␣2 to IR1a and IR1b in vitro. EMSAs were performed using (A) human hIR1a, (B) mouse/rat m/
rIR1a, or (C) IR1b as probe. Nuclear extracts were prepared from Huh 7 cells transfected with FXR␣1 or FXR␣2. The specificity of the
binding was established with competition assays using competing oligonucleotides, including unlabeled or mutated probe with 10× concentration. Identification of FXR protein in the shifted complex was carried out by supershift assays using polyclonal Abs against human
FXR. The shifted bands representing the specific binding of FXR to the probe or FXR Abs to FXR/DNA complex are indicated by
arrows.

with wt promoter when the chromatins were immunoprecipitated with anti-FXR Abs but not with IgG (Fig. 9A).
More importantly, a PCR band with a relatively weaker signal was also detected in cells transfected with IR1a mutant.
In contrast, no obvious bands were detected in cells transfected with either IR1b mutant or IR1ab double mutant
(Fig. 9A). The data thus established that FXR␣1 was specifically recruited to IR1b but not IR1a in intact Huh 7
cells. On the other hand, with FXR␣2, a PCR band was
readily detected in cells transfected with wt and IR1b mutant, whereas no signals were detected in cells transfected
with IR1a and IR1ab double mutant (Fig. 9B). The data
thus demonstrated that FXR␣2 was specifically recruited
to IR1a but not IR1b.

Sequence differences between hIR1a and m/rIR1a
were primarily responsible for the species-specific
transactivation of BSEP by FXR␣1 and FXR␣2
Sequence alignment of IR1a and IR1b in BSEP promoters from seven species including human, pongo pygmaeus,
pan troglodytes, horse, dog, rat, and mouse revealed that
IR1b was completely conserved (Fig. 11A), indicating the

Fig. 9. Recruitment of FXR␣1 and FXR␣2 to IR1a and IR1b in intact cells. ChIP assays were carried out
using chromatins prepared from Huh 7 cells cotransfected with (A) FXR␣1 or (B) FXR␣2 with human BSEP
promoter reporter wt, IR1a, IR1b, or IR1ab double mutant. After immunoprecipitated with anti-FXR Abs or
IgG as negative control, recruitment of FXR␣1 or FXR␣2 to IR1a or IR1b was detected by PCR using a set of
primers, BSEP(-260b) and pGL-R(122), flanking the two IR1 sites in the reporter plasmid DNA. A negative
control primer set, BSEP(-995b) and BSEP(-805b), was used to amplify a fragment approximately 700b upstream the IR1 sites. Input chromatin DNA was included as a positive PCR control.
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FXR␣1 and FXR␣2 acted independently in
transactivating human BSEP
To investigate whether FXR␣1 and FXR␣2 have additive
or competitive effects on the transactivation of human BSEP
IR1a element reporter and full-length promoter, increasing amounts of FXR␣1 were cotransfected with a constant
amount of FXR␣2, followed by detection of the transactivation levels. As shown in Fig. 10A, FXR␣1 competitively
decreased FXR␣2-mediated transactivation in cells transfected with IR1a element reporter pGL3/p-2xhIR1a. In
contrast, FXR␣1 had minimal effects on FXR␣2-mediated
transactivation of the full-length promoter reporter phBSEP
(-2.6kb), even at the highest dose (Fig. 10B). The results

indicated that FXR␣1 competitively bound to IR1a with
FXR␣2 in the IR1a element reporter, which is consistent
with the data from EMSA (Fig. 8A). The results also indicated that no competitive binding of FXR␣1 to IR1a occurred in the full-length promoter, which is consistent with
the data from the ChIP assays (Fig. 9A). Such discrepancy
in FXR␣1’s effects on FXR␣2-mediated transactivation of
IR1a element and full-length promoter indicated that the
context of IR1a played a determinant role in responding
to FXR␣1. It was thus concluded that in the content of fulllength promoter, FXR␣1 and FXR␣2 transactivated human
BSEP independently through IR1b and IR1a, respectively
and that BSEP expression levels were predominately determined by FXR␣2.
Combining the data from transactivation, mutational
analysis, EMSA and ChIP assays, it was concluded that
FXR␣1 and FXR␣2 regulated human BSEP independently
through IR1b and IR1a. On the other hand, mouse and
rat bsep are regulated by FXR␣1 through both IR1a and
IR1b and by FXR␣2 through IR1a (Fig. 10C).

importance of the element in regulating BSEP expression.
On the other hand, IR1a was less conserved with 62% sequence identity among those species.
To determine whether the species-specific regulation of
BSEP by FXR␣1 and FXR␣2 is due to the differences in IR1a,
two chimeric promoter reporters in which the authentic IR1a
3040
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DISCUSSION
As the limiting step in bile acid enterohepatic circulation, canalicular efflux of bile acids by BSEP is tightly regulated by the bile acids/FXR signaling pathway. In our
previous study, it was found that human BSEP was isoformdependently regulated by FXR, with FXR␣2 being the
predominant regulator. The relative expression of FXR␣1
and FXR␣2 was altered in HCC patients and associated
with dysregulation of BSEP (25). Similar FXR isoformdependent transactivation has been reported for other
FXR targets, including ileal bile acid-binding protein (24),
fibrinogens (26), syndecan-1 (27), and ␣-crystallin (31).
However, it is currently not understood how FXR␣1 and
FXR␣2 exhibit different activity on those FXR targets.
Based on EMSA data, it was postulated that FXR␣2 had a
higher binding affinity than FXR␣1 to the FXRE of the
targets (24). Such notion is consistent with the fact that
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Fig. 10. Interrelationship between FXR␣1 and FXR␣2. The effects of FXR␣1 on FXR␣2-mediated transactivation of (A) human
IR1a element reporter pGL3/p-2xhIR1a and (B) full-length human BSEP promoter reporter phBSEP(-2.6kb) were investigated.
Increasing amounts of FXR␣1 were cotransfected with a constant
amount of FXR␣2 and pGL3/p-2xhIR1a or phBSEP(-2.6kb). Vector pcDNA5 plasmid DNAs were also cotransfected to obtain a constant total plasmid DNA in each well. Sixteen hours posttransfection,
cells were treated with DMSO (0.1%) or CDCA (10 M) for 30 h,
followed by detection of luciferase activity. The data are presented
as mean ± SD of at least three repeated experiments. (C) A diagram summarizing FXR␣1- and FXR␣2-mediated transactivation
of BSEP through IR1a and IR1b. In human, FXR␣1 and FXR␣2
regulate BSEP exclusively through IR1b and hIR1a, respectively.
In mouse and rat, FXR␣1 is able to transactivate BSEP through
both m/rIR1a and IR1b, whereas FXR␣2 transactivates exclusively
through m/rIR1a.

was replaced with the IR1a from other species were constructed and tested for their ability to respond to FXR␣1 and
FXR␣2. As shown in Fig. 11B, replacement of the hIR1a in
the human BSEP promoter reporter phBSEP(-2.6kb) with
m/rIR1a resulted in a strong transactivation of the chimeric
promoter reporter phBSEP(2.6kb)-m/rIR1a by both FXR␣1
and FXR␣2, a pattern comparable to mouse or rat promoter
wt (Fig. 1). On the other hand, the reciprocal chimera
prBSEP(-2kb)-hIR1a in which the m/rIR1a of rat bsep promoter reporter prBSEP(-2kb) was replaced with human hIR1a
exhibited an isoform-dependent transactivation by FXR␣1
and FXR␣2 as human BSEP promoter wt (Fig. 11C).
To further confirm the results, the wt and chimeric promoter reporters were injected into mice, and their transactivation activities in vivo were evaluated by IVIS living imaging.
As shown in Fig. 11D, strong luciferase signals were detected
in mice injected with wt rat bsep promoter reporter prBSEP(2.0kb), while no detectable signals were observed in mice received wt human BSEP promoter reporter phBSEP(-2.6kb),
indicating that rat bsep promoter has much stronger activity
than human BSEP promoter. Replacement of mouse/rat
IR1a with human hIR1a in prBSEP(-2.0kb)-hIR1a markedly
reduced the signal compared with wt rat bsep promoter reporter. On the other hand, substitution of the human IR1a
with mouse/rat m/rIR1a in phBSEP(-2.6kb)-m/rIR1a resulted in noticeable elevation of luciferase signals compared
with wt human BSEP promoter reporter. Taken together, the
data firmly established that the sequence differences in IR1a
were primarily responsible for the species-specific regulation
of BSEP by FXR␣1 and FXR␣2.
To determine whether the observed differences in BSEP
promoter activities between mouse and human is reflected
by the endogenous BSEP transcription levels, the BSEP
mRNA levels in human and mouse liver tissues were quantified by real-time PCR with GAPDH levels as internal controls. As shown in Fig. 11E, the mRNA level of mouse bsep
was significantly higher than that of human BSEP. The
data thus demonstrated that mouse bsep was transcribed
at a much higher level than human BSEP in vivo.
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Fig. 11. IR1b is completely conserved among species, whereas IR1a is primarily responsible for the species
difference in transactivation of BSEP by FXR␣1 and FXR␣2. (A) Sequences of the IR1a and IR1b from seven
species including mouse, rat, dog, cat, horse, primate, and human were aligned. The overall conservation
percentages of IR1a and IR1b are indicated. (B) The hIR1a in human BSEP promoter reporter phBSEP(-2
.6kb) was replaced with mouse/rat m/rIR1a, generating a chimeric reporter pBSEP(-2.6kb)-m/rIR1a. (C)
The rIR1a in rat bsep promoter reporter prBSEP(-2kb) was replaced with human hIR1a, resulting a chimeric
reporter prBSEP(-2kb)-hIR1a. Human and rat bsep promoter wt and chimeric reporters were cotransfected
with FXR␣1 or FXR␣2 into Huh 7 cells, followed by treatment of transfected cells with DMSO (0.1%) or
CDCA (10 M) for 30 h. Reporter activities were detected by the dual-luciferase reporter assay system. The
data are presented as mean ± SD of at least three repeated experiments. (D) Female CD-1 mice were randomly
divided into four groups. Each group of mice was hydrodynamically injected with either phBSEP(-2.6kb),
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transactivation of human BSEP through IR1b is critical for
maintaining BSEP expression in the events of low total
FXR levels.
Although FXR␣1 abundantly bound to hIR1a and
FXR␣2 weakly associated with IR1b in vitro in EMSAs (Fig.
8A, C), and FXR␣1 competitively decreased FXR␣2mediated transactivation of IR1a reporter (Fig. 10A), it
was concluded that FXR␣1 and FXR␣2 did not bind to
hIR1a and IR1b in the full-length promoter content in intact cells, respectively, based on the following considerations: first, recruitments of FXR␣1 to hIR1a and FXR␣2
to IR1b were not detected in intact cells with the ChIP assays (Fig. 9A, B); second, FXR␣1 failed to transactivate
hIR1a reporter (Fig. 5A); and third, overexpression of
FXR␣1 had a negligible effect on FXR␣2-mediated transactivation of the full-length promoter (Fig. 10B), indicating no competition between the two for binding to IR1a.
Taken together, the data strongly supported the conclusion that FXR␣1 and FXR␣2 exclusively bind to IR1b and
IR1a, respectively, in intact cells. Such discrepancy of FXR
binding to FXRE between in vitro and in intact cells indicates that FXR binding to FXRE within cells is governed
not only by the sequence but also by the content. Such notion is supported by the finding that among the 1.7 million
FXREs predicted in the mouse genome, only 1,656 (32) or
7,794 (30) FXREs were detected for FXR binding in vivo
in the liver.
In the ChIP assays, it was noticed that compared with wt
promoter, the recruitment of FXR␣1 to IR1b in the IR1a
mutant or FXR␣2 to IR1a in the IR1b mutant was decreased (Fig. 9A, B). One possible explanation for such
phenomenon is that mutation in one site has a negative
impact on the binding of FXR␣1 or FXR␣2 to the other
site due to the proximity of the two sites (18 bases apart).
It should be noted that the ChIP assays were carried out on
the transfected wt and mutant promoters. Definitive evidence for FXR␣1 binding to IR1b or FXR␣2 binding to
IR1a in the endogenous BSEP promoter remains to be
provided.
In contrast to human BSEP, mouse and rat bsep were
comparably transactivated by FXR␣1 and FXR␣2 (Fig. 1).
Mouse and rat m/rIR1a is able to support both FXR␣1and FXR␣2-mediated transactivation as the FXRE consensus (FXREc: AGGTCA N TGACCT) does (data not shown).
Comparing the sequences of hIR1a, IR1b, and m/rIR1a
with FXREc, m/rIR1a is the closest to FXREc, followed by
IR1b and hIR1a. Detailed analysis of the sequences revealed that a nucleotide G at position 2 is conserved among
FXREc, m/rIR1a, and hIR1a but altered to T in IR1b.
Therefore, the G at position 2 may play a determinant role
in mediating FXR␣2 transactivation. On the other hand,
nucleotides A and T in positions 1 and 13 are conserved

prBSEP(-2kb), phBSEP(-2.6kb)-m/rIR1a, or prBSEP(-2kb)-hIR1a promoter reporter. Luciferase activities as
luminescent signals were detected by living imaging IVIS 48 h postinjection and captured by a CCD camera
with an exposure of 45 s. (E) BSEP mRNA levels in human and mouse liver tissues were quantified by TaqMan real-time PCR. Using GAPDH mRNA levels as internal standards, the relative mRNA expression levels
of BSEP in human and mouse liver tissues were compared. Median value of each group is indicated by a
short line. Mann-Whitney nonparametric test was used for pair-wise comparison.
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the four amino acid residues inserted in FXR␣1 are located immediately after the DNA binding domain (DBD).
The insertion may alter the conformational structure in
DBD, thus compromising its ability to bind to FXRE. However, in this study, we showed that FXR␣1 and FXR␣2
transactivated human BSEP through two FXREs, IR1b
and IR1a, respectively. The question remains how FXR␣1mediated transactivation through IR1b is much weaker
than FXR␣2-mediated activation through IR1a in human
BSEP. One possible explanation is that FXR␣1 might have
a weaker intrinsic activity than FXR␣2. However, such notion is inconsistent with the results that FXR␣1 transactivated mouse and rat bsep as potently as did FXR␣2 (Fig. 1).
Another more likely explanation is that the sequence and/
or the content of the IR1b are not optimal for maximal
activation by FXR␣1.
Considering that FXR␣2-mediated transactivation
through IR1a is the predominant pathway regulating human BSEP expression, the question remains regarding
the physiological significance of FXR␣1-mediated transactivation through IR1b in regulating human BSEP. One
possible physiological function of FXR␣1/IR1b pathway
is to support the maximal transactivation of BSEP by the
FXR␣2/IR1a pathway. Consistent with such speculation
are results from the mutational studies that mutation in
IR1b markedly reduced FXR␣2-mediated basal as well as
CDCA-induced transactivation of human BSEP (Fig. 7B).
Searching the IR1b sequence in the database revealed
that IR1b element is present in many promoter regions
(data not shown). However, it remains to be determined
whether IR1b element is involved in regulating any of
those genes.
Our results showed that in addition to total FXR levels,
relative FXR isoform expression levels (FXR␣1/FXR␣2
ratios) significantly affected human BSEP expression. In
healthy human liver tissues, FXR␣1/FXR␣2 ratios ranged
from 1.09 to 1.63, with an average of 1.37, while BSEP expression exhibited 24-fold differences. It was our expectation that as the FXR␣1/FXR␣2 ratios increased, BSEP
expression would decrease. However, the actual data revealed that the relationship between FXR␣1/FXR␣2 ratio
and BSEP expression was dependent on the total FXR expression levels (Fig. 2A, B). As expected, human BSEP expression decreased as the ratios increased at the higher
levels of total FXR. However, in contrast to our expectation, BSEP expression increased as the FXR␣1/FXR␣2 ratio increased at the lower levels of total FXR. We were not
able to provide a satisfactory explanation for the relationship exhibited at the lower levels of total FXR. Such phenomenon may be related to FXR␣1’s specific activation
through IR1b. Since IR1b is completely conserved among
species, it is reasonable to speculate that FXR␣1-mediated
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